An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer
ConclusionOur study implicates statin-induced SREBP2 activation as a PCa vulnerability that can be exploited for therapeutic purposes using clinically-approved agents.
Source: Molecular Metabolism - Category: Endocrinology Source Type: research
More News: Cancer | Cancer & Oncology | Cholesterol | Endocrinology | Fluvastatin | Genetics | Prostate Cancer | Rosemary | Statin Therapy | Study